- Home
- GLDD vs OCS Comparison
GLDD vs OCS Comparison
Compare GLDD & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- OCS
- Stock Information
- Founded
- GLDD 1890
- OCS 2003
- Country
- GLDD United States
- OCS Switzerland
- Employees
- GLDD N/A
- OCS N/A
- Industry
- GLDD Military/Government/Technical
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- GLDD Industrials
- OCS Health Care
- Exchange
- GLDD Nasdaq
- OCS Nasdaq
- Market Cap
- GLDD 671.1M
- OCS 689.8M
- IPO Year
- GLDD 2006
- OCS N/A
- Fundamental
- Price
- GLDD $11.18
- OCS $19.45
- Analyst Decision
- GLDD Buy
- OCS Strong Buy
- Analyst Count
- GLDD 1
- OCS 4
- Target Price
- GLDD $14.00
- OCS $31.50
- AVG Volume (30 Days)
- GLDD 679.9K
- OCS 29.0K
- Earning Date
- GLDD 05-06-2025
- OCS 05-08-2025
- Dividend Yield
- GLDD N/A
- OCS N/A
- EPS Growth
- GLDD 79.53
- OCS N/A
- EPS
- GLDD 1.02
- OCS N/A
- Revenue
- GLDD $806,898,000.00
- OCS $847,333.00
- Revenue This Year
- GLDD $9.13
- OCS $53.79
- Revenue Next Year
- GLDD $4.58
- OCS $1,860.95
- P/E Ratio
- GLDD $10.94
- OCS N/A
- Revenue Growth
- GLDD 28.03
- OCS N/A
- 52 Week Low
- GLDD $7.51
- OCS $10.79
- 52 Week High
- GLDD $12.89
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- GLDD 63.31
- OCS 58.76
- Support Level
- GLDD $10.50
- OCS $17.33
- Resistance Level
- GLDD $11.33
- OCS $20.45
- Average True Range (ATR)
- GLDD 0.29
- OCS 0.80
- MACD
- GLDD -0.03
- OCS 0.19
- Stochastic Oscillator
- GLDD 64.76
- OCS 68.75
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.